[Left ventricular function in essential hypertension during isoproterenol infusion]

Area of Science:

• Cardiology
• Hypertension Research
• Cardiac Physiology

Context:

• Essential hypertension is a major risk factor for cardiovascular disease.
• Cardiac hypertrophy, a common complication of hypertension, can lead to impaired left ventricular function.
• Understanding the functional consequences of cardiac hypertrophy in hypertension is crucial for patient management.

Purpose:

• To investigate the effects of isoproterenol (ISP) on left ventricular function in patients with essential hypertension, stratified by the presence or absence of cardiac hypertrophy.
• To determine the relationship between left ventricular mass (LVM) and left ventricular dysfunction in hypertensive individuals.

Summary:

• M-mode echocardiograms were used to assess left ventricular function at rest and during ISP infusion in hypertensive patients with (Group HH) and without (Group NH) cardiac hypertrophy, and in normotensive controls.
• Group HH showed significantly decreased peak negative dD/dt (diastolic function) and peak positive dD/dt (systolic function) after ISP infusion, which correlated inversely with LVM.
• Hypertensive patients with cardiac hypertrophy exhibited diastolic and latent systolic left ventricular dysfunction, exacerbated by ISP and related to increased LVM.

Impact:

• This study highlights the detrimental effects of cardiac hypertrophy on left ventricular function in essential hypertension.
• Findings suggest that increased LVM contributes to both diastolic and systolic dysfunction in hypertensive patients.
• The results underscore the importance of managing cardiac hypertrophy to preserve left ventricular function in hypertension.